Clearance for Botox Expanded by U.S. FDA

FDA clearance for Botox has been expanded this month, allowing physicians to treat spasticity in muscles of the elbow, wrist and fingers. Such conditions can occur after a stroke, injury or debilitating disease.

The Food and Drug Administration specified that Botox treatment is not intended to be a substitute for physical therapy or the “usual standard of care rehabilitation regimens.”

Treatment applications for Botox seem to be expanding all the time. While it is best known for its cosmetic purposes — typically the treatment of forehead wrinkles or “frown lines” –there are several therapeutic treatments now being offered by doctors today. Hyperhidrosis, cervical dystonia and muscle spasm are just a few of those alternative treatments.

Tags: ,

This entry was posted on Monday, March 29th, 2010 at 8:45 am and is filed under Botox. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply